Physician

Mohamed Nael Tarakji, M.D.

According to 2025 Medicare claims, Mohamed Tarakji, M.D. (NPI: 1336241082) practices neurology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is FLINT NEUROLOGICAL CENTRE PC (NPI: 1952402612; TIN: 383189890) and primary practice location at 48532-3411. Tarakji is affiliated with the Genesys PHO, L.L.C. (ACO ID: A2597), participating under the MSSP model.

Tarakji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 384 traditional Medicare patients, billed 2,819 HCPCS/CPT codes, and received $286,197 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 7,842 prescription claims across 699 beneficiaries totaling $1,253,877 in drug costs, led by Panzyga (Immun Glob G(Igg)-Ifas/Glycine). DME data shows 16 claims. Open Payments data shows 84 records totaling $9,029. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $582,897 to $286,197. Similarly, Part D prescription costs have declined steadily, from $2,751,268 to $1,253,877. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$291K$583K2015 Medicare payment: $582,897 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $541,084 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $471,947 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $471,083 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $485,816 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $332,731 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $353,404 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $371,055 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $318,433 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $286,197 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1325,542$582,897
20169535,186$541,084
20178754,670$471,947
20187934,445$471,083
20197374,433$485,816
20205713,274$332,731
20214743,064$353,404
20224973,192$371,055
20234442,843$318,433
20243842,819$286,197

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.6M$3.2M2015 Drug cost: $2,751,268 (USD; Tot_Drug_Cst)2016 Drug cost: $2,842,417 (USD; Tot_Drug_Cst)2017 Drug cost: $3,039,029 (USD; Tot_Drug_Cst)2018 Drug cost: $3,222,499 (USD; Tot_Drug_Cst)2019 Drug cost: $2,951,176 (USD; Tot_Drug_Cst)2020 Drug cost: $2,541,102 (USD; Tot_Drug_Cst)2021 Drug cost: $2,411,783 (USD; Tot_Drug_Cst)2022 Drug cost: $2,404,712 (USD; Tot_Drug_Cst)2023 Drug cost: $2,350,172 (USD; Tot_Drug_Cst)2024 Drug cost: $1,253,877 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,31115,826$2,751,268
20161,31516,821$2,842,417
20171,30816,946$3,039,029
20181,32117,130$3,222,499
20191,33117,294$2,951,176
20201,23016,294$2,541,102
20211,10913,757$2,411,783
20221,16914,915$2,404,712
20231,16615,352$2,350,172
20246997,842$1,253,877

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.9K$3.9K2015 Medicare payment: $3,885 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,590 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,174 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,885 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,231 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $3,192 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $1,655 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,723 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,020 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,639 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20154255$3,885
20163939$3,590
20172727$2,174
20183535$2,885
20192326$2,231
20203234$3,192
20211819$1,655
20221616$1,723
20231111$1,020
20241516$1,639

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
95819Measurement of brain wave activity (eeg), awake and asleep246271$287
20526Injection of carpal tunnel174425$78
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more319798$78
95886Needle measurement of electrical activity in arm or leg muscles, complete study148460$64
92653Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report158160$56

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
PanzygaImmun Glob G(Igg)-Ifas/Glycine12336$295,130
Kesimpta PenOfatumumab261,004$280,699
TysabriNatalizumab11326$98,047
BriviactBrivaracetam581,740$81,991
AptiomEslicarbazepine Acetate301,320$70,844

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L3908Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelfN1516$1,639

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.84$9,029ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mohamed Nael Tarakji, M.D.?

Tedicare shows public-source Medicare data for Mohamed Nael Tarakji, M.D. (NPI 1336241082), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed Nael Tarakji, M.D. have ACO affiliation data?

Mohamed Nael Tarakji, M.D. is shown with ACO affiliation data for Genesys PHO, L.L.C. (MSSP, ACO ID A2597).

What billing organization is linked to Mohamed Nael Tarakji, M.D.?

Mohamed Nael Tarakji, M.D. is linked to FLINT NEUROLOGICAL CENTRE PC (billing NPI 1952402612) in the available physician profile data.

Does Mohamed Nael Tarakji, M.D. have Open Payments data?

Mohamed Nael Tarakji, M.D. has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.